What is the purpose of pharmacotherapies during alcohol withdrawal, and which agents are commonly used?

• A. To treat underlying depression.
• B. To increase energy during withdrawal.
• C. To replace psychotherapy.
• D. To prevent severe withdrawal and seizures; benzodiazepines guided by CIWA-Ar with taper; thiamine supplementation essential.

Answer: (D)

The primary aim of pharmacotherapies during alcohol withdrawal is to prevent progression to severe withdrawal and seizures while safely managing symptoms. Benzodiazepines are the main agents used because they reduce CNS hyperexcitability and lower the risk of life-threatening complications like seizures and delirium tremens. Dosing is guided by a withdrawal scale such as CIWA-Ar, which assesses tremors, agitation, autonomic symptoms, and other signs; as the score changes, doses are adjusted and gradually tapered to prevent rebound symptoms as alcohol effects wear off. Thiamine supplementation is essential because many people with chronic heavy use are malnourished and thiamine-deficient, and deficiency can lead to Wernicke’s encephalopathy (and Korsakoff syndrome) if untreated. In practice, common pharmacotherapies include benzodiazepines (like lorazepam, diazepam, or chlordiazepoxide) used in a CIWA-Ar guided taper, along with thiamine given early in withdrawal. These approaches address urgent withdrawal risks and nutritional deficiencies, rather than treating underlying mood disorders, increasing energy, or replacing psychotherapy.